F11R and ductal breast carcinoma in situ: Immunohistochemical staining and semi-quantitative scoring (Figure 1A) of DCIS patient cases (n = 50) revealed that 96% of DCIS cores had moderate/high JAM-A expression versus only 23% of normal adjacent tissue cores (n = 26 patients; Figure 1B; p < 0.0001).